Federal award
NOVA BIOMEDICAL CORP
W81K0021P0100
Contract
Obligated and Ceiling
- Obligated (net)
- $82,360.00
- Ceiling (potential value, not spending)
- $82,360.00
- Current value
- $82,360.00
- Gross positive obligations
- $109,150.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0021P0100
- Award type code
- B
- Actions
- 12 · Jun 29, 2021 to Dec 22, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 22, 2025 | FY2026 | P00011 | C | $20,550.00 | — |
| Apr 24, 2025 | FY2025 | P00010 | G | $0.00 | — |
| Oct 30, 2024 | FY2025 | P00009 | C | $20,550.00 | — |
| Jul 24, 2024 | FY2024 | P00008 | C | −$10,080.00 | — |
| Jun 2, 2024 | FY2024 | P00007 | G | $0.00 | — |
| Nov 1, 2023 | FY2024 | P00006 | C | $20,550.00 | — |
| Aug 4, 2023 | FY2023 | P00005 | G | $0.00 | — |
| Jan 19, 2023 | FY2023 | P00004 | C | −$16,710.00 | — |
| Nov 1, 2022 | FY2023 | P00003 | C | $20,550.00 | — |
| Apr 21, 2022 | FY2022 | P00002 | G | $0.00 | — |
| Nov 3, 2021 | FY2022 | P00001 | C | $26,950.00 | — |
| Jun 29, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.